Results 181 to 190 of about 83,984 (282)
Highly purified cannabidiol (CBD) in CDKL5 deficiency disorder (CDD): Open‐label prospective study
Abstract Objective CDKL5 deficiency disorder (CDD) is an early‐onset developmental and epileptic encephalopathy characterized by frequent drug‐resistant seizures, cerebral visual impairment, motor dysfunction, and sleep and gastrointestinal disturbances.
Marco Perulli +12 more
wiley +1 more source
Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy. [PDF]
Jesudian AB +7 more
europepmc +1 more source
ABSTRACT Background Spontaneous bacterial peritonitis (SBP) remains a life‐threatening complication in cirrhotic patients with refractory ascites. Evidence for rifaximin (RFX) in SBP prevention and prognosis is lacking in Japan. We investigated the effect of RFX on prognosis and recurrence of SBP and evaluated the prognostic role of oral health within ...
Yoshihito Uchida +10 more
wiley +1 more source
Nurse‐Led Clinic for Patients With Decompensated Liver Cirrhosis
ABSTRACT Background and Aims Prognosis for patients with decompensated liver cirrhosis is poor and readmissions are frequent. Closer and more structured follow‐up by nurses may prevent readmissions and stabilize liver‐related complications. We aimed to test the hypothesis that establishing a nurse‐led clinic for patients with decompensated liver ...
Elsebeth E. Kelstrup +5 more
wiley +1 more source
S100B protein as a marker of minimal hepatic encephalopathy. [PDF]
Pisarek W +2 more
europepmc +1 more source
ABSTRACT Background Tolvaptan promotes electrolyte‐free water excretion and is widely used in Asia for ascites, but in Western countries its use is limited to hyponatremia because of hepatotoxicity concerns. Methods We performed a retrospective cohort study using the TriNetX Research Network, emulating a target trial of cirrhotic patients with ...
Kazuya Okushin +5 more
wiley +1 more source
Development of a tryptophan metabolomics-based diagnostic model for hepatic encephalopathy in liver cirrhosis. [PDF]
Cao X, Wang L, Ning L, Hu Y, Fu N.
europepmc +1 more source
Differential Mortality Risk by Age in Males and Females With Steatotic Liver Disease
Data on the impact of sex for overall and cause‐specific mortality in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) is limited. Among older (>50 years) people with MASLD, males had about 40% higher risk of overall and nonliver related mortality, while the opposite was observed with females having about 30% higher risk ...
Taotao Yan +11 more
wiley +1 more source

